This inventor holds 5 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Amgen Inc., Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique. Active years: 2004-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:






Years Active: 2004-2023
Title: The Innovative Contributions of Santos A. Susin in Cancer Treatment
Introduction
Santos A. Susin, an inventive mind based in Paris, France, is recognized for his significant contributions to the field of pharmaceuticals, especially in cancer treatment. With a total of five patents to his name, his inventions reflect a deep commitment to advancing medical science and improving patient outcomes.
Latest Patents
Santos A. Susin's latest patents focus on groundbreaking compounds and their pharmaceutical uses in treating cancer. One notable patent details a compound or a pharmaceutical salt that comprises a hexapeptide sequence, enabling its application in anticancer therapy. This innovation also includes a pharmaceutical composition that contains soluble peptides, nucleic acids, expression vectors, or host cells, all paired with a pharmaceutically acceptable carrier for efficacy in cancer treatment.
Additionally, another prominent patent pertains to a soluble peptide composed of the amino acid sequence KRFYVVMWKK (SEQ ID NO:1) or its function-conservative variants. This invention supports cancer treatment through its incorporation into a pharmaceutical composition, signaling a step forward in targeted therapies.
Career Highlights
Throughout his career, Santos A. Susin has lent his expertise to prominent research institutions, notably the Institut National de la Santé et de la Recherche Médicale. His work there has been instrumental in bridging the gap between scientific research and practical applications, leading to transformative therapeutic solutions.
Collaborations
Collaboration has been a key aspect of Susin's work. He has worked alongside notable scientists such as Philippe Karoyan and Josef Martin Penninger, fostering an environment of innovation and shared knowledge. These collaborations have likely enriched his research and contributed to his successful patent portfolio.
Conclusion
Santos A. Susin stands out as a pioneering inventor whose work in the realm of cancer treatment has the potential to change lives. With his innovative patents, he continues to inspire those in the fields of medicine and pharmaceuticals, demonstrating the power of invention in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile